Debiopharm
Edit

Debiopharm

https://www.debiopharm.com/
Last activity: 24.04.2024
Categories: ActiveDevelopmentDrugFinTechHealthTechLifeManufacturingMedtechProduct
Debiopharm is a well-established, family-owned biopharmaceutical group of companies based in Lausanne, Switzerland. Founded in 1979 by Rolland-Yves Mauvernay, Debiopharm identifies high-potential compounds for In-licensing, clinical development and commercialisation with partners across the globe.
Likes
333
Followers
674
Followers
15.53K
Website visits
8.6K /mo.
Mentions
68
Location: Switzerland, Vaud, Lausanne
Employees: 201-500
Phone: +41 21 321 01 11
Founded date: 1979

Investors 2

Mentions in press and media 68

DateTitleDescriptionSource
24.04.2024Risklick launches flagship product following an investment b... Developing new therapies typically requires an average of ten years and costs up to two billion dol...startuptic...
09.01.2024MedaSystems Secures Additional Funding from Debiopharm Innov...MENLO PARK, Calif. & LAUSANNE, Switzerland–(BUSINESS WIRE)–January 9, 2024– MedaSystems, a pione...venturebea...
29.09.2023Debiopharm launches new seed fund for cancer care & phar...Read this article in: Lausanne, Switzerland-based Debiopharm Innovation Fund, the strategic investme...siliconcan...
28.09.2023Debiopharm to invest in seed stage companiesstartuptic...
28.09.2023USD 3.4M to foster Tune Insight visionstartuptic...
28.09.2023Debiopharm Innovation Fund Launches Seed Funding ActivityDebiopharm Innovation Fund, the Lausanne, Switzerland-based strategic investment arm of Swiss biopha...finsmes.co...
25.05.2023Debiopharm Partners with Genedata to Digitalize Translationa...By consolidating large amounts of diverse, multi-source data & making it easy for our teams to u...prweb.com/...
17.05.2023DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATIN...Glioblastomas (GBM) are among the most aggressive and lethal tumors of the central nervous system wi...en.prnasia...
30.03.2023Slovenian Genialis raises $13M to improve diseases treatment...Slovenian Genialis raises $13M to improve diseases treatment with AI and ML 30 March, 2023, 10:24 ...ain.capita...
22.03.2023DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY F...Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnos...en.prnasia...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In